These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 8142297)
21. Characteristics of estrogen-2/4-hydroxylase of porcine ovarian follicles: influence of steroidal and non-steroidal agents on the activity of the enzyme in vitro. Mondschein JS; Hammond JM; Weisz J J Steroid Biochem; 1987 Jan; 26(1):121-4. PubMed ID: 3821099 [TBL] [Abstract][Full Text] [Related]
22. Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor. Bhatnagar AS; Häusler A; Schieweck K; Lang M; Bowman R J Steroid Biochem Mol Biol; 1990 Dec; 37(6):1021-7. PubMed ID: 2149502 [TBL] [Abstract][Full Text] [Related]
23. In vitro potency and selectivity of the non-steroidal androgen aromatase inhibitor CGS 16949A compared to steroidal inhibitors in the brain. Wozniak A; Holman SD; Hutchison JB J Steroid Biochem Mol Biol; 1992 Oct; 43(4):281-7. PubMed ID: 1390279 [TBL] [Abstract][Full Text] [Related]
24. Selective aromatase inhibition by pyridoglutethimide, an analogue of aminoglutethimide. Kitawaki J; Yamamoto T; Urabe M; Tamura T; Inoue S; Honjo H; Okada H Acta Endocrinol (Copenh); 1990 May; 122(5):592-8. PubMed ID: 2353556 [TBL] [Abstract][Full Text] [Related]
25. CGS 16949A, a new nonsteroidal aromatase inhibitor: effects on hormone-dependent and -independent tumors in vivo. Schieweck K; Bhatnagar AS; Matter A Cancer Res; 1988 Feb; 48(4):834-8. PubMed ID: 2962734 [TBL] [Abstract][Full Text] [Related]
26. Formation of 4-oestrene-3,17-dione (19-norandrostenedione) by porcine granulosa cells in vitro is inhibited by the aromatase inhibitor 4-hydroxyandrostenedione and the cytochrome P-450 inhibitors aminoglutethimide phosphate and ketoconazole. Khalil MW; Morley P; Glasier MA; Armstrong DT; Lang T J Endocrinol; 1989 Feb; 120(2):251-60. PubMed ID: 2926299 [TBL] [Abstract][Full Text] [Related]
27. Antiproliferative effect of the new aromatase inhibitor fadrozole on pre- and postmenopausal models of rat mammary tumor. Tanaka M; Yano S; Hasegawa Y; Nakao K Arzneimittelforschung; 1994 Jun; 44(6):774-8. PubMed ID: 8053980 [TBL] [Abstract][Full Text] [Related]
28. Comparison of aromatase activity in human prostatic, testicular and placental tissues. Rowlands MG; Davies JH; Shearer RJ; Dowsett M J Enzyme Inhib; 1991; 4(4):307-13. PubMed ID: 1727017 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of rat liver microsomal estrogen 2-hydroxylase by 2-methoxyestrogens. Brueggemeier RW; Singh U J Steroid Biochem; 1989 Oct; 33(4A):589-93. PubMed ID: 2811369 [TBL] [Abstract][Full Text] [Related]
30. Aromatase and estrogen 2-hydroxylase activities of human placental microsomes in pregnancy-induced hypertension. Okubo K; Jinbo M; Toma Y; Shimizu Y; Yanaihara T Endocr J; 1996 Aug; 43(4):363-8. PubMed ID: 8930523 [TBL] [Abstract][Full Text] [Related]
31. Effects of aromatase inhibitors, aminoglutethimide, and 4-hydroxyandrostenedione on cyclic rats and rats with 7,12-dimethylbenz(a)anthracene-induced mammary tumors. Wing LY; Garrett WM; Brodie AM Cancer Res; 1985 Jun; 45(6):2425-8. PubMed ID: 3921242 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of estrogen synthetase (aromatase) by 4-cyclohexylaniline. Kellis JT; Vickery LE Endocrinology; 1984 Jun; 114(6):2128-37. PubMed ID: 6723577 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of rat liver estrogen 2/4-hydroxylase activity by troleandomycin: comparison with erythromycin and roxithromycin. Fisher D; Labbe G; Berson A; Tinel M; Loeper J; Larrey D; Pessayre D J Pharmacol Exp Ther; 1990 Sep; 254(3):1120-7. PubMed ID: 2395109 [TBL] [Abstract][Full Text] [Related]
34. Evidence that estradiol-2/4-hydroxylase activities in rat hypothalamus and hippocampus differ qualitatively and involve multiple forms of P-450: ontogenetic and inhibition studies. Theron CN; Russell VA; Taljaard JJ J Steroid Biochem; 1985 Dec; 23(6A):919-27. PubMed ID: 4094419 [TBL] [Abstract][Full Text] [Related]
35. The inhibition of human prostatic aromatase activity by imidazole drugs including ketoconazole and 4-hydroxyandrostenedione. Ayub M; Levell MJ Biochem Pharmacol; 1990 Oct; 40(7):1569-75. PubMed ID: 2222512 [TBL] [Abstract][Full Text] [Related]
36. Effects of Fadrozole (CGS 16949A) and Letrozole (CGS 20267) on the inhibition of aromatase activity in breast cancer patients. Demers LM Breast Cancer Res Treat; 1994; 30(1):95-102. PubMed ID: 7949208 [TBL] [Abstract][Full Text] [Related]
37. The effects of CGS 16949A, an aromatase inhibitor on adrenal mineralocorticoid biosynthesis. Demers LM; Melby JC; Wilson TE; Lipton A; Harvey HA; Santen RJ J Clin Endocrinol Metab; 1990 Apr; 70(4):1162-6. PubMed ID: 2156889 [TBL] [Abstract][Full Text] [Related]
38. Antitumor effects of a nonsteroidal aromatase inhibitor (CGS 16949A) on 7, 12-dimethylbenz[alpha]anthracene-induced mammary tumors in rats. Iino Y; Sugamata N; Owada S; Tago T; Sato H; Yokoe T; Maemura M; Morishita Y; Horiuchi R Jpn J Clin Oncol; 1991 Jun; 21(3):153-9. PubMed ID: 1834875 [TBL] [Abstract][Full Text] [Related]
39. Reversible inhibition of human placental microsomal aromatase by CGS 18320B and other non-steroidal compounds. Bullion KA; Osawa Y; Braun DG Endocr Res; 1990; 16(2):255-67. PubMed ID: 2140551 [TBL] [Abstract][Full Text] [Related]
40. Postmenopausal estrogen synthesis and metabolism: alterations caused by aromatase inhibitors used for the treatment of breast cancer. Lønning PE; Dowsett M; Powles TJ J Steroid Biochem; 1990 Mar; 35(3-4):355-66. PubMed ID: 2139151 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]